Literature DB >> 330411

Suppression of babesiosis in BCG-infected mice and its correlation with tumor inhibition.

I A Clark, E J Wills, J E Richmond, A C Allison.   

Abstract

Infection of mice with Bacillus Calmette-Guérin (BCG) provided good protection against Babesia species. The intensity and duration of this protection was similar to that established after natural recovery from babesiosis. It developed too soon after the first exposure to the parasite, and was too radioresistant, to be attributable to specific antibody production. In addition, the parasites degenerated within circulating erythrocytes. This phenomenon is inconsistent with phagocytosis or lysis of parasites or parasitized cells, or prevention of entry of parasites into erythrocytes, causing the observed protection. Hence the phenomenon is best explained by the release of a nonspecific mediator that can limit multiplication of parasites within erythrocytes. These results not only throw light on mechanisms of immunity against hemoprotozoa. There are many points of similarity between the nonspecific protection BCG and Corynebactium parvum provide against Babesia species and inhibition of tumor growth by these agents. Therefore, babesiosis in mice may be a convenient experimental model for assessing stimulation of the mononuclear phagocyte system, which appears to be the basis of nonspecific immunity against bacteria, parasites, and tumors.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 330411      PMCID: PMC421139          DOI: 10.1128/iai.17.2.430-438.1977

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  29 in total

1.  Transmission of BCG-associated tumor resistance from maternal to newborn guinea pigs.

Authors:  P Minden; J Sandridge; M A Wainberg; J K McClatchy
Journal:  J Natl Cancer Inst       Date:  1976-01       Impact factor: 13.506

2.  Corynebacterium-induced protection against artificial pulmonary metastases of a syngeneic fibrosarcoma in mice.

Authors:  L Milas; N Hunter; H R Withers
Journal:  Cancer Res       Date:  1974-03       Impact factor: 12.701

3.  Effect of Corynebacterium parvum treatment on the growth of Salmonella enteritidis in mice.

Authors:  F M Collins; M T Scott
Journal:  Infect Immun       Date:  1974-05       Impact factor: 3.441

4.  An endotoxin-induced serum factor that causes necrosis of tumors.

Authors:  E A Carswell; L J Old; R L Kassel; S Green; N Fiore; B Williamson
Journal:  Proc Natl Acad Sci U S A       Date:  1975-09       Impact factor: 11.205

5.  Corynebacterium parvum as a therapeutic antitumor agent in mice. I. Systemic effects from intravenous injection.

Authors:  M T Scott
Journal:  J Natl Cancer Inst       Date:  1974-09       Impact factor: 13.506

6.  The growth of tumours in T-cell deprived mice and their response to treatment with Corynebacterium parvum.

Authors:  M Woodruff; N Dunbar; A Ghaffar
Journal:  Proc R Soc Lond B Biol Sci       Date:  1973-08-31

Review 7.  Corynebacterium parvum as an immunotherapeutic anticancer agent.

Authors:  M T Scott
Journal:  Semin Oncol       Date:  1974-12       Impact factor: 4.929

8.  Tumor suppression by a lymphokine released into the circulation of mice with delayed hypersensitivity.

Authors:  S B Salvin; J S Youngner; J Nishio; R Neta
Journal:  J Natl Cancer Inst       Date:  1975-11       Impact factor: 13.506

9.  Effect of immunization with attenuated Mycobacterium bovis on experimental toxoplasmic retinochoroiditis.

Authors:  K J Tabbara; G R O'Connor; R A Nozik
Journal:  Am J Ophthalmol       Date:  1975-04       Impact factor: 5.258

10.  Two new inhibitory activities in blood of mice with delayed hypersensitivity, after challenge with specific antigen.

Authors:  S B Salvin; J Nishio; J T Shonnard
Journal:  Infect Immun       Date:  1974-04       Impact factor: 3.441

View more
  20 in total

1.  The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections.

Authors:  J Drews
Journal:  Infection       Date:  1985       Impact factor: 3.553

2.  Mycobacterium-induced potentiation of type 1 immune responses and protection against malaria are host specific.

Authors:  Kathleen R Page; Anne E Jedlicka; Benjamin Fakheri; Gregory S Noland; Anup K Kesavan; Alan L Scott; Nirbhay Kumar; Yukari C Manabe
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

3.  Induction of enhanced resistance against encephalomyocarditis virus infection of mice by nonviable Mycobacterium tuberculosis: mechanisms of protection.

Authors:  D L Lodmell; L C Ewalt
Journal:  Infect Immun       Date:  1978-12       Impact factor: 3.441

4.  Suppressed or enhanced antibody responses in vitro after BCG treatment of mice: importance of BCG viability.

Authors:  C A Brown; I N Brown; V S Sljivić
Journal:  Immunology       Date:  1979-11       Impact factor: 7.397

5.  Role of T cells in preventing transmission of rodent malaria.

Authors:  P G Harte; N C Rogers; G A Targett
Journal:  Immunology       Date:  1985-09       Impact factor: 7.397

6.  Immunostimulation. Clinical and experimental perspectives.

Authors:  J Drews
Journal:  Klin Wochenschr       Date:  1984-03-15

7.  The experimental and clinical use of immune-modulating drugs in the prophylaxis and treatment of infections.

Authors:  J Drews
Journal:  Infection       Date:  1984 Mar-Apr       Impact factor: 3.553

8.  Malaria infections in different strains of mice and their correlation with natural killer activity.

Authors:  E M Eugui; A C Allison
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

9.  Resistance to Babesia spp. and Plasmodium sp. in mice pretreated with an extract of Coxiella burnetii.

Authors:  I A Clark
Journal:  Infect Immun       Date:  1979-05       Impact factor: 3.441

10.  Effect of BCG on the resistance of rats to infection with Fasciola hepatica.

Authors:  R C Thompson; M J Howell
Journal:  Z Parasitenkd       Date:  1979
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.